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Abstract
Highly phagocytic macrophages line the marginal zone (MZ) of the spleen and the lymph node subcapsular sinus. Although
these macrophages have been attributed with a variety of functions, including the uptake and clearance of blood and
lymph-borne pathogens, little is known about the effector mechanisms they employ after pathogen uptake. Here, we have
combined gene expression profiling and RNAi using a stromal macrophage cell line with in situ analysis of the
leishmanicidal activity of marginal zone macrophages (MZM) and marginal metallophilic macrophages (MMM) in wild type
and gene targeted mice. Our data demonstrate a critical role for interferon regulatory factor-7 (IRF-7) in regulating the killing
of intracellular Leishmania donovani by these specialised splenic macrophage sub-populations. This study, therefore,
identifies a new role for IRF-7 as a regulator of innate microbicidal activity against this, and perhaps other, non-viral
intracellular pathogens. This study also highlights the importance of selecting appropriate macrophage populations when
studying pathogen interactions with this functionally diverse lineage of cells.
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Introduction
Mononuclear phagocytes are widely distributed in all tissues,
and provide a broad range of homeostatic and immune functions
during development and throughout adult life. Nevertheless, the
heterogeneity of mature tissue macrophages represents one of the
most striking, yet under-studied, features of mononuclear cell
differentiation. Expression of a range of transcription factors and
cellular receptors has helped define membership of the mononu-
clear phagocyte system [1,2,3], and whereas some tissue
macrophages have a capacity for local self-renewal, others are
derived from blood-borne monocytes undergoing tissue-specific
differentiation [reviewed in [4]]. In lymphoid tissues, macrophage
heterogeneity is most strikingly evident. For example in mice,
readily distinguishable populations of macrophages are found in
the splenic MZ, red pulp, B cell follicles and white pulp [5].
Moreover, within the MZ, SIGNR-1
+MARCO
+ MZM occupy
the outer rim adjacent to the red pulp, and CD169
hi MMM
border the lymphocyte-rich white pulp [5,6,7,8,9,10]. Mice
lacking various transcription factors (e.g. relb and NFkB2), TNF
superfamily cytokines (e.g. LTa), and chemokines (e.g. CCL19/
21ser) exhibit steady-state defects in MZ macrophage differenti-
ation and/or positioning [11,12], illustrating the complexity
behind this micro-anatomical organisation.
MZM and MMM are well-placed in the marginal sinus to
encounter blood borne antigens and pathogens. MZM are avidly
phagocytic, are well-characterised as facilitating clearance of
Streptococcus pneumoniae from the blood stream [13,14,15] and are
involved in the initiation of Type I T-independent immune
responses [16]. MMM, whilst also phagocytic [17] are better
recognised for playing a role in antigen transport into B cell
follicles [4] and are also known to be robust producers of IFN-a
following infection with viral pathogens [18]. MMM, and to a
lesser extent MZM, also express CD169, a sialoadhesin first
described on bone marrow ‘stromal’ macrophages involved in the
support of erythropoiesis [19] and these cells may provide this or
other stromal functions in the spleen. Similarly, in lymph nodes,
subcapsular sinus macrophages mark a point of entry for viruses
and bacteria entering via the afferent lymphatics and are
intimately involved in the initiation of antibody responses
[20,21,22]. Thus, various specialised macrophages populations
are ideally situated within secondary lymphoid tissues to first
encounter pathogens that enter the blood and lymphatics.
Nevertheless, despite their importance in providing a ‘gate-
keeper’ function, little is known about how these tissue resident
macrophages subsequently deal with the pathogens they encoun-
ter. Direct study of MZM and MMM has been problematic and
only rarely reported [6], largely because of the inherent technical
difficulties in isolating these scarce and fragile cells for functional
analysis in vitro. Hence, our understanding of the effector
functions of MZM and MMM is largely extrapolated from that
of other diverse macrophage populations, such as those derived
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under the influence of CSF-1. In this study, therefore, we set out to
directly identify the mechanism by which splenic MZM and
MMM are able to kill intracellular Leishmania parasites. We first
identified a stromal macrophage cell line (14M1.4; [23]) that
displayed similar innate capacity to kill L. donovani as observed in
MZM and MMM. By gene expression profiling, we showed that
Leishmania infection stimulated expression of the transcription
factor Irf-7, as well as redistribution of cellular IRF-7 from
MyD88
+ endosomes to the Leishmania-containing phagosome.
Initial control of intracellular Leishmania by 14M1.4 cells involved
NO and was minimally affected by silencing of Irf-7. However,
subsequent leishmanicidal activity strictly required Irf-7 and was
NO-independent. Furthermore, Irf-7 loss-of-function could not be
overcome by exogenous IFN-a, suggesting a downstream effector
mechanism uncoupled from Irf-7-dependent amplification of IFN-
a. By immunohistochemistry of spleens from infected mice, we
showed that MZM and MMM also responded to infection with
heightened expression and phagosomal recruitment of IRF-7.
Finally, we showed that MZM and, to a lesser extent, MMM from
Irf-7-deficient mice were unable to kill intracellular Leishmania.B y
focusing on these tissue-resident stromal macrophages, we have
thus identified a new role for IRF-7 as a regulator of macrophage
anti-leishmanial activity, and demonstrated that this transcription
factor plays a role in innate effector responses to a broader range
of intra-phagosomal pathogens than previously recognised.
Results
IFN-c-independent killing of Leishmania by stromal
macrophages
Previous studies in BALB/c mice showed that after i.v.
injection, L. donovani amastigotes are rapidly and selectively taken
up by MZM and MMM, and that over the following 24h, parasite
load in the MZ was significantly reduced [17]. We first confirmed
this selectivity of uptake in the MZ of C57BL/6 mice, observing
greater than 90% of amastigotes in the MZ (within cells staining
either for CD169 or SIGNR1) and few parasites in either the deep
white pulp or in the red pulp (Figure 1A). To confirm that
C57BL/6 mice also expressed rapid leishmanicidal activity and to
determine whether this might be mediated by NK cell-derived
IFN-c [24], we treated mice with either control IgG or anti-IFN-c.
Both control and anti-IFN-c-treated mice reduced parasite load to
a similar extent, indicating that this response was largely IFN-c
Author Summary
Macrophages are phagocytic cells that play a dual role in
infection. They can kill ingested micro-organisms and thus
help eliminate the threat from infection, but some
pathogens have adapted to survive within macrophages
and use the intracellular niche they provide as a means of
immune evasion. Although it has long been recognised
that macrophages in different tissues look and behave
differently, this heterogeneity is rarely taken into account
when examining macrophage-pathogen interactions. By
comparing gene expression profiles of different types of
macrophages, we show here the diversity of the macro-
phage response to Leishmania donovani infection. In one
cell line that resembles the macrophages of the spleen
that are targets of L. donovani infection, we identified a
gene expression signature more similar to that expected
for a viral infection, and by using RNAi, identified that the
transcription factor IRF-7 played an essential role in the
selective capacity of these macrophages to kill this
intracellular parasite. The importance of this pathway of
host resistance was directly confirmed by examining the
response of splenic macrophages in Irf-7-deficient mice.
This comparative approach has, therefore, identified a new
molecular pathway involved in the innate tissue-specific
control of L. donovani infection.
Figure 1. Splenic marginal zone macrophages and marginal metallophilic macrophages control L. donovani by an IFN-c
independent mechanism. (A) L. donovani amastigotes are found predominantly in MMM and MZM after intravenous injection (purple, SIGNR1;
green CD169; white, L. donovani; blue DAPI). (B) C57BL/6 mice were treated with 0.5mg XMG 1.6 anti-IFN-c IgG (black bars) or control IgG (open bars)
and 2h later infected with L. donovani. At 5h and 24h p.i., the number of parasites per MZ area was determined. (C) 14M1.4 cells (black bars) and RAW
264.7 cells (open bars) were infected with L. donovani (MOI 10:1) and at indicated times p.i., parasite numbers per 100 macrophages were determined
by fluorescence microscopy. *, p,0.05, **, p,0.01 between bars indicated as indicated. Scale bar; 200mm.
doi:10.1371/journal.ppat.1000813.g001
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macrophage cell lines (RAW264.7, J774.1, 14M1.4) and primary
macrophage populations (bone marrow-derived, peritoneal) for
their ability to kill L. donovani amastigotes in the absence of IFN-c
activation. Of the cells tested, 14M1.4 cells were striking in their
ability to clear amastigotes over a 24–48h period. Infected 14M1.4
cells reduced parasite load by ,50% from 6h–12h after infection
and sustained this activity over the subsequent 36h, resulting in
almost complete clearance of amastigotes by 48h (Figure 1C). In
contrast, although RAW264.7 reduced the number of intracellular
amastigotes by ,30–40% from 12h–24h, no further reduction in
parasite load was detected after this time. Differences in
amastigote numbers were not readily attributable to differential
rates of cell division between 14M1.4 cells and other cells tested,
with 14M1.4 and RAW264.7 cells showing similar levels of CFSE
dilution over 48h (Supplementary Figure S1A). Likewise,
equivalent levels of CFSE dilution were observed in intracellular
amastigotes isolated from both cell populations, indicating that
parasite growth rate was similar in these two host cells
(Supplementary Figure S1B). Thus, these data collectively
demonstrated that 14M1.4 cells were intrinsically very efficient at
killing intracellular amastigotes.
Gene expression profiling of stromal macrophages
To understand further the mechanism(s) by which 14M1.4 cells
killed intracellular amastigotes, we used global gene expression
profiling to examine the transcriptional response of 14M1.4 cells to
L. donovani infection. 977 and 851 genes were found to be
differentially expressed in infected vs. control 14M1.4 cells at 12h
or 48h p.i. respectively, using a cut-off of a 2-fold change in gene
expression (Supplementary Tables S1 and S2). These
differentially expressed genes were analysed by generating gene
interaction networks using Ingenuity Pathways Analysis software.
10 networks of high interconnectivity ($20 differentially regulated
genes) were constructed for genes differentially regulated at 12h
p.i. and 12 hubs at 48h p.i (Supplementary Figure S2 and S3).
In contrast, only 136 and 161 genes were differentially regulated in
RAW264.7 cells, at 12h and 48h p.i. respectively (Supplemen-
tary Tables S3 and S4), and only one hub with high
interconnectivity could be identified at each time point (Supple-
mentary Figure S2 and S3). In 14M1.4 cells, the highest
scoring networks reflected genes involved in interferon signalling
(notably Irf-7, Irf-1, Stat-2), cytokines (notably Il-6) and cardinal
interferon response genes (including mx-1, Rsad and various MHC
and MHC related genes: Figure 2A and B). At 48h, 31% of
genes (9/29) listed in the Ingenuity Pathways ‘Interferon
Signalling’ pathway were represented in the differentially induced
gene set, all being upregulated. Within the ‘Antigen Presentation
Pathway’, 25% (10/39) were either up- or down-regulated, with a
marked differential response between MHCI-and MHCII-associ-
ated genes (Figure 2B). A range of genes within these networks
and associated with pathogen recognition and handling were also
down-regulated including Irf-8, recently associated with the innate
control of intra-phagosomal pathogens [25], Cx3cr1, a chemokine
receptor involved in the NO-dependent bactericidal activity of
macrophages [26], Clec7a (Dectin-1) and Clec4a (Mincle), both
associated with fungal recognition [27,28] and Msr1, the
macrophage scavenger receptor and its cytoplasmic partner
Hook3 [29,30]. Sc5d, associated with cholesterol synthesis [31]
was also down-regulated, in keeping with data indicating that
Leishmania infection depletes this membrane lipid [32,33], as was
Emr1 (F4/80; [34]). TGFb and a network of interconnected genes
were also specifically down-regulated at 48h in 14M1.4 cells
(Supplementary Figure S3).
We next performed clustering using the CLICK algorithm
contained in EXPANDER [35] which identified 550 genes in a
single cluster(homogeneityvalue:0.895)thatwereincreasedintheir
expression level at both 12h and 48h p.i. (Figure 2C). GO
functional classes representing ‘immune response’ (GO:0006955;
5.45%) and ‘defense response’ (GO: 0006952; 0.54%) were
significantly enriched in this cluster. We next used PRIMA software
[36] to identify transcription factor sequences enriched amongst
these 550 induced genes. By this analysis (Figure 2D), we identified
Irf-7 and Irf-1 and ISRE, as potential regulators of the response of
14M1.4 cells to L. donovani. Similar analysis of genes down regulated
in 14M1.4 cells at both time points did not reveal any significantly
enriched transcription factors (data not shown).
Based on the high levels of expression in 14M1.4 cells, absence
of expression of an interferon response signature in RAW264.7
cells, and the known role of Irf-7 as a central regulator of the Type
I interferon response [37,38], we focused further attention on Irf-7.
Confirmation of the induction of Irf-7 following Leishmania
infection was obtained by quantitative RT-PCR (Figure 2E), by
intracellular flow cytometry (Figure 2F) and by confocal
microscopy (Figure 2G). Amastigotes induced a dose- and time-
dependent accumulation of Irf-7 mRNA and IRF-7 protein in
14M1.4 cells that was similar in kinetics but of somewhat reduced
magnitude than poly(I:C) a known Toll-like receptor (TLR)-3-
dependent inducer of Irf-7. In contrast, RAW264.7 cells and bone
marrow-derived macrophages induced minimal levels of Irf-7
mRNA accumulation or IRF-7 protein expression (Supplemen-
tary Figure S4). Together, these data indicated that 14M1.4
stromal macrophages, but not RAW 264.7 macrophages respond-
ed to L. donovani infection by strong induction of IRF-7.
IRF-7 is recruited to the Leishmania phagosome
In IRF-7/MyD88 co-transfected RAW264.7 and HEK 293 cells
and in plasmacytoid DC, IRF-7 and MyD88 co-localise in
endosomes [39]. To establish whether such co-localisation also
occurred in un-manipulated 14M.1.4 cells and to gain further
insight into IRF-7 activation in these cells, we examined the
distribution of MyD88 and IRF-7 by confocal microscopy
(Figure 3). In resting 14M1.4 cells, IRF7 and MyD88 were largely
co-localised in small cytoplasmic vesicles, with little evidence of
nuclear IRF-7 (Figure 3A; Video S1, shown as a snapshot in
Figure 3E). Following poly(I:C) activation, nuclear translocation of
IRF-7 occurred, with residual cytoplasmic IRF-7 remaining
associated with MyD88 containing vesicles (Figure 3B). In sharp
contrast, although 14M1.4 cells infected for 48h withL. donovani also
hadnuclearIRF-7,cytoplasmicIRF-7 wasnow primarilyassociated
with phagosomes containing Leishmania, and rarely with MyD88
+
vesicles (Figure 3C). By 48h p.i., almost all L. donovani phagosomes
were IRF-7
+ (Figure 3D). IRF-7 was almost undetectable in
RAW264.7 macrophages, with or without infection, but where low
levels of IRF-7 could be seen in rare cells, an association with the L.
donovani phagosome was not apparent (Supplementary Figure
S4). Of interest, IRF-7 in infected 14M1.4 cells was almost always
localised to one pole of the phagosome (Figure 3C insert; Video
S2, shown as a snapshot in Figure 3F). The recruitment and
polarisation of IRF-7 in the Leishmania phagosome was specific,
based on three sets of observations. First, MyD88 was not similarly
detected at this location (Figure 3C and F). Second, in 14M1.4
macrophages treated with poly(I:C) and then exposed to latex beads
for 48h, no phagosomal recruitment of IRF-7 was observed in spite
of high levels of induction of IRF-7 (Figure 3G). Third, TLR3
accumulating on latex and Leishmania phagosomes did not show the
polar distribution seen with IRF-7 on Leishmania phagosomes
(Figure 3G and H). With TLR3 used to demarcate the
IRF-7 Mediated Killing of Leishmania
PLoS Pathogens | www.plospathogens.org 3 March 2010 | Volume 6 | Issue 3 | e1000813Figure2.Inductionofaninterferon-responsesignaturein14M1.4cells followingL.donovani infection.Expression profilingof 14M1.4 cells,
with and without infection with L. donovani was performed using Affymetrix gene array. (A and B) Networks showing up (red) and down (green)
regulated genes48hafterL. donovani infection were generated usingIngenuity Pathways; (A)‘antimicrobial response’ and(B)‘antigenpresentation’. (C)
Differentially expressed genes were clustered using CLICK. 550 genes were significantly induced at both 12h and 48h p.i. (D) Transcription factor
enrichment analysis using PRIMA identified IRF-7, IRF-1 and ISRE as significantly enriched in the 550 gene cluster shown in (C). Number of genes in each
set is indicated in brackets. (E) Real-time RT-PCR showing Irf-7 mRNA accumulation in 14M1.4 following exposure to L. donovani at MOI of 30:1
(diamond), 10:1 (invert triangle), 1:1 (triangle) or after exposure to 100mg/ml poly(I:C) (open square) . (F) Kinetics of IRF-7 expression on 14M1.4 cells
following exposure to L. donovani at a MOI of 10:1 for 6 (open grey line), 12 (open thin black line), 24h (open thick black line) or 48h (angled hatch) or to
100mg/ml poly (I:C) (filled gray). Control untreated cells are also shown (vertical hatch) (G) Expression of IRF-7 by confocal microscopy (red, IRF-7; blue,
DAPI) in uninfected (left) and L. donovani- infected (right) 14M1.4 cells. Amastigotes are indicated by arrowheads. Scale bar: 10mm.
doi:10.1371/journal.ppat.1000813.g002
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mal localisation (Figure 3H), an observation that was supported by
using LAMP1 as an alternative phagosome membrane marker
(Figure 3I and Video S3). Although some co-localisation with
LAMP1 was observed, a significant amount of the observed IRF-7
was clearly intra-phagosomal, either on,within or tightly apposedto
the amastigote itself. In summary, these data demonstrate that
dissociation of endosomal MyD88 and IRF-7 is followed by nuclear
and phagosomal recruitment of IRF-7.
To determine whether the IRF-7 response in 14M1.4 cells
actually reflected the response of MZM and MMM to Leishmania
infection in situ, we prepared tissue sections from control and L.
donovani-infected mice, and analysed IRF-7 expression (Figure 4).
IRF-7 expression was minimal in MMM (Figure 4A) and MZM
(Figure 4B) of naı ¨ve mice, but readily observed at 5h (data not
shown) and 24h in MMM (Figure 4C) and MZM (Figure 4D)o f
infected C57BL/6 mice. At 5h p.i., ,90% and at 24h p.i. ,65%
of parasite-containing phagosomes had clearly associated IRF-7
staining (Figure 4E), and although it was difficult to always assess
the subcellular distribution of IRF-7, a polar distribution, similar
to that seen in 14M1.4 cells in vitro, was often observed (Video
S4, shown as a snapshot in Figure 4F). Collectively, these
data support the contention that the early leishmanicidal activity
of splenic MZ macrophage populations is also accompanied by
IRF-7 induction and recruitment of IRF-7 to the amastigote-
containing phagosome.
IRF-7 is required for leishmanicidal activity
To directly determine whether IRF-7 induction was involved in
regulating the leishmanicidal activity of 14M1.4 cells, we performed
functional gene knock down of IRF-7 using RNAi. Knock-down
clones were screened by RT-PCR (Figure 5A) and immunofluo-
rescence(Figure5B–E)inthe presenceorabsenceofpoly(I:C),and
two independent clones with strong inhibition of Irf-7 mRNA
accumulation were selected for further study (KD#1a n dK D #2).
Analysis of the fate of L. donovani in Irf-7 knock-down compared to
control cells indicated that control of parasite burden was biphasic
with respect to the requirement for Irf-7. Amastigote numbers were
reduced to a similar extent over the first 12h of infection in all cells
tested, suggesting an early phase of leishmanicidal activity that was
Irf-7-independent. In contrast, sustained leishmanicidal activity,
measured over 12–48h, was completely abrogated by knock-down
of Irf-7 (Figure 5F). Thus, the leishmanicidal response of 14M1.4
cells consisted of an immediate Irf-7-independent component and a
late-acting Irf-7-dependent component ultimately responsible for
amastigote clearance.
Involvement of NO and IFN-a in Irf-7-dependent killing
IRF-7 plays a central role in the amplification of the Type I IFN
response [37] and NO has been reported to have a major role as a
leishmanicidal effector in macrophages exposed to either Type I
IFNs [40] or IFN-c [41]. We therefore determined whether NO
and IFN-a were involved in the killing of Leishmania by 14M1.4
cells. Although only minimal amounts of NO could be detected in
Figure 3. IRF-7 is recruited to Leishmania phagosomes. Untreated
(A), poly(I:C)-treated (B) and 48h L. donovani-infected (C) 14M1.4 cells
were stained for IRF-7 (red) and MyD88 (green). Cells were counter-
stained with DAPI (blue) and analysed by confocal microscopy. Single
confocal slices are shown. Amastigotes are indicated with arrowheads
and enlarged in inset in (C). (D) Frequency of IRF-7
+ phagosomes was
scored at time intervals shown in infected 14M1.4 and RAW264.7 cells.
(E, F) Snap shots from Video S1 and S2, showing IRF-7-MyD88
association in untreated 14M1.4 cells (E) and phagosomal ‘capping’ of
IRF-7 in Leishmania-infected 14M1.4 cells (F) (red, IRF-7; green, MyD88;
blue, DAPI.). (G) 14M1.4 cells stimulated with poly (I:C) and allowed to
phagocytose latex beads (arrow), stained for IRF-7 (red) and TLR3
(green). (H) 14M1.4 cells infected with L. donovani and stained for TLR3
(green) and IRF-7 (red). Scale bars; 10mm. (I) Snap shot from Video S3,
showing IRF-7 and LAMP1 staining in 24h Leishmania-infected 14M1.4
cells (red, IRF-7; green, MyD88; blue, DAPI).
doi:10.1371/journal.ppat.1000813.g003
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Figure S5), treatment of 14M1.4 cells with the Nos2 inhibitor
aminoguanidine (AMG) blocked their ability to rapidly kill L.
donovani as measured over the first 12h p.i. (Figure 5G). Likewise,
AMG also blocked the early leishmanicidal activity of Irf-7-
deficient 14M1.4 cells (Figure 5H). In contrast, AMG had a
minimal effect on the late phase of leishmanicidal activity in
14M1.4 cells (with parasite burden continuing to decrease steadily
from 12–48h) or in Irf-7-deficient 14M1.4 cells (with amastigote
numbers remaining at similar levels or increasing slightly from 12–
48h; Figure 5G, H). Thus, whereas NO played a role in
immediate parasite killing, it had limited involvement in the
subsequent Irf-7-dependent phase of leishmanicidal activity.
Next, we exposed wild type and knock down 14M1.4 cells to
exogenous IFN-a. At early time points (,12h), exogenous IFN-a
significantly enhanced the rate at which wild type, but not Irf-7-
deficient, 14M1.4 cells killed L. donovani (Figure 5G, H),
suggesting that the early augmentation of effector function
mediated by exogenous IFN-a required the presence of Irf-7.
Importantly, however, at later time points (12–48h) exogenous
IFN-a was unable to overcome the loss-of-function associated with
Irf-7-deficiency (Figure 5H). Thus, leishmanicidal activity in
14M1.4 macrophages involves i) an early NO-dependent and Irf-
7-independent component, which can nevertheless be augmented
by IFN-a in an Irf-7-dependent manner and ii) a late-acting NO-
independent, Irf-7-dependent component which can not be
compensated for by exogenous IFN-a.
Killing of Leishmania in the MZ requires IRF-7
The existence of an Irf-7-dependent leishmanicidal pathway in
14M1.4cells led us to investigate whether innate killing of Leishmania
in the marginal zone was similarly controlled by IRF-7. In contrast
to what has been observed with other interferon regulatory factor-
deficient mice, no obvious structural differences were observed
in the organisation and cellular content of the marginal zone in
Irf-7
2/2 mice before or after infection (Figure 6A–F). However,
in contrast to B6 mice, B6.Irf-7
2/2 mice failed to eliminate
intracellular amastigotes over the first 24h of infection (Figure 6G).
To determine whether Irf-7-dependent killing was a property of
both MMM and MZM, we separately scored the change in
amastigote number within these two populations (Figure 6H). In
B6 mice, MMM and MZM both significantly reduced their parasite
load from 5h to 24h (by 62% and 37% respectively; p,0.001). In
Irf-7
2/2 mice, although MMM were still able to reduce amastigote
load by ,33% (P,0.001), killing activity was clearly reduced in
comparison to MMM in wild type mice (p,0.001). For MZM, the
impact of Irf-7-deficiency was more striking, with Irf-7
2/2 MZM
failing to display any killing activity. Thus, IRF-7playedan essential
role in regulating the innate ability of splenic tissue macrophages to
kill L. donovani in vivo. In the course of these studies, we also noted
that in B6.Irf-7
2/2 , but not in B6 mice, amastigotes could be found
more readily within red pulp macrophages (Figure 6E and F),
suggesting that the barrier function of the marginal zone that
prevents early amastigote dissemination may also be impaired by
Irf-7 deficiency.
Discussion
MZM and MMM have previously been shown to be involved in
the uptake of various blood borne pathogens, and in this way
provide an important barrier to systemic infection
[7,10,13,14,15,17,18]. Although macrophages in the marginal
zone have been shown to be capable of IFN-a production [9,18],
Figure 4. IRF-7 is induced in MZM and MM in situ. (A–D) Induction of IRF-7 in MMM and MZM. Naı ¨ve (A,B) and C57BL/6 mice infected for 24h
(C, D) were stained for CD169 (A, C; green) or SIGNR1 (B, D; green), IRF-7 (red) and L. donovani (white). (E) The percentage of IRF-7
+ parasite-
containing phagosomes was quantified by counting 100 amastigotes/section (n=3) and calculating the proportion of parasites with IRF-7
accumulation. *, p,0.05 (F) Snap shot from Video S4, showing infected MMM with phagosomal localisation of IRF-7 (CD169
+ green, IRF-7, red; LV9,
white; DAPI, blue). Scale bars; 50mm.
doi:10.1371/journal.ppat.1000813.g004
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in vitro study of other macrophage populations. Here, using a
comparative approach involving direct in vitro and in vivo analysis
of microbicidal activity, we provide evidence that IRF-7 plays a
central role in regulating the ability of MZM and MMM to control
the intra-phagosomal pathogen, L. donovani. Although IRF-7 has
long been acknowledged to orchestrate anti-viral immune
responses, a role in macrophage effector responses to non-viral
pathogens has not been previously described.
IRF-7 has been shown to co-localise with MyD88 in endosomes
of IRF-7 and MyD88 transfected cell lines [39], an observation we
confirmed here using non-transfected 14M1.4 cells. Our studies
extendtheseobservationsbyshowingthatupon Leishmania infection,
the spatiotemporal link between MyD88 and IRF-7 was lost.
Whereas MyD88 remained associated with small cytoplasmic
vesicles, IRF-7 was selectively recruited to Leishmania-containing
phagosomes, both in vitro in 14M1.4 cells and in vivo in infected
MZM and MMM. This recruitment of IRF-7 was specific and not
observed with latex bead phagosomes, even in cells also containing
Leishmania or in cells highly activated for IRF-7 expression using
poly(I:C). It remains to be formally demonstrated whether this
change in IRF-7 localisation reflects i) dissociation of IRF-7 from
existing complexes with MyD88 and subsequent re-location to the
phagosome, or ii) whether such IRF-7 undergoes nuclear
translocation, with only de novo synthesised IRF-7 being recruited
to phagosomes. Based on the short half life of IRF-7 [42] and the
kineticsofmRNAaccumulationdescribed here,wecurrentlyfavour
the latter possibility. Interestingly, the absence of detectable MyD88
on the Leishmania phagosome, along with the absenceof phagosomal
TLR 9 expression (Phillips et al, unpublished observations) suggests
that MyD88-dependent phagosomal signaling may not be a
significant feature of Leishmania infection in these cells, at least at
the time points studied. Similarly, it remains to be determined
whether phagosomal IRF-7 plays any functional role in the IRF-7-
dependent leishmanicidal activity observed here. On the one hand,
phagosomal recruitment of IRF-7 might lead to IRF-7 forming part
of a signalosome complex at the phagosome membrane, as has been
described for phagosome-recruited AP-1 [43]. On the other hand,
our confocal analysis suggests that the bulk of phagosomal IRF7 is
intra-phagosomal (as defined by LAMP1) and likely to be associated
with the amastigote itself. This observation is strikingly similar to
that made by Antoine and colleagues who demonstrated acquisition
Figure 5. IRF-7-dependent killing of Leishmania in 14M1.4 cells. (A) Silencing of Irf-7 in 14M1.4 cells using lentiviral shRNA generated two
clones (KD#1 and KD#2) with .95% knockdown in mRNA accumulation after poly(I:C) induction. (B–E) IRF-7 expression in untreated wild type
14M1.4 (B), in RNAi-control 14M1.4 cells (C) and in KD#1 (D) and KD#2 (E) clones. (F) Wild type 14M1.4 cells (open bars), RNAi control 14M1.4 cells
(hatch bars), KD#1 (black bars) and KD#2 (grey bars) cells were infected with L. donovani and the parasite load per 100 cells was determined at the
times indicated. *, p,0.05, **, p,0.01, ***, p,0.005 comparing 14M1.4 and knock-down clones. (G and H) 14M1.4 (G) and KD#1 (H) cells were
treated with aminoguanidine (circle) or exogenous IFN-a (invert triangle) or untreated (square) then infected with L. donovani. Infection was
determined from replicate cultures at times indicated. Scale bars; 10mm.
doi:10.1371/journal.ppat.1000813.g005
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amastigotes [44] and suggests that the amastigote might act as a
‘sink’ that accumulates phagosome-associated IRF-7. These two
possibilities are not mutually exclusive, and we do indeed see low
levels of IRF-7 co-localized with LAMP1 apparently in the
phagosome membrane. Nevertheless, given that the amastigotes
of L. donovani also have tight attachment sites to the phagosomal
membrane [45]; and Phillips and Kaye, unpublished), future studies
employing immunogold EM, cell fractionation and biochemical
approaches will be required to determine the exact localization of
IRF-7 in the L. donovani phagosome and whether such IRF-7 plays a
functional role.
The mechanism of killing we observe in 14M1.4 cells, in MZM
and, to a lesser extent, MMM appears distinct from that previously
reported for Leishmania studied in other macrophage populations.
Innate IFN-c-independent control over L. donovani in hepatic and
splenic macrophages is a function often attributed to Slc11a1 [46].
However, this phagosomal iron transporter exerts leishmanistatic
control over amastigote growth and, in any case, 14M1.4 cells
carry the mutant allele of Slc11a1. Similarly, expression profiling
suggests that a number of other recently identified anti-microbial
pathways are down-regulated in 14M1.4 cells after Leishmania
infection. Although a role for NO in IFN-c-independent killing of
Leishmania has also been established [41], our data indicate that the
major phase of Irf-7-dependent killing occurs in a largely NO-
independent manner. That previous studies have failed to identify
this pathway may reflect the stromal origin of 14M1.4 cells and
their closer relationship to resident tissue macrophages such as
MZM and MMM. For example, RAW264.7 cells, a commonly
used cell line in the study of Leishmania-macrophage interactions,
responds minimally to infection with IRF-7 induction, and hence
this pathway would not be evident in studies using this host-
pathogen combination. Indeed, our data emphasize the impor-
tance of studying appropriate tissue macrophages when aiming to
identify physiologically relevant effector mechanisms. Importantly,
our data do not argue against a role for IFN-a in the regulation of
Irf-7 [42]. IFN-a could be produced either through an autocrine
pathway (as with 14M1.4 cells in vitro) or through a combination
of autocrine and paracrine pathways, as is more likely to affect
MZM and MMM in vivo. Indeed, plasmacytoid DC (pDC), a
major source of IFN-a are readily activated after Leishmania
infection [[47] and Sanos and Kaye, unpublished). Rather, our
finding that exogenous IFN-a could not compensate for Irf-7 loss-
of-function provides evidence for an alternative downstream
effector mechanism that cannot be amplified by IFN-a alone.
Further studies to identify potential phagosomal effectors regulated
by Irf-7 are currently in progress.
Our studies were not designed to directly address the question of
recognition of L. donovani during the process of early phagocytic
uptake. Nevertheless, recent work has suggested that TLR9 is
involved in the recognition of L. infantum and L. major promasti-
gote-derived genomic DNA by CD11c
+ cDC and by pDC [48]. In
these published studies, however, no attempt was made to
determine the immediate consequences of this recognition for
the subsequent control of Leishmania survival. Using RAW264.7
macrophages, Descoteaux and colleagues suggested a role for both
TLR2 and TLR3 in the phagocytic uptake of L. donovani
promastigotes and a role for TLR3 in the leishmanicidal activity
of the IFN-gamma-primed macrophages. However, as reported
here, RAW264.7 cells do not recapitulate the IRF-7 response
observed in 14M1.4 cells, MZM and MMM and these cells show
only limited leishmanicidal activity in the absence of IFN-c
activation. Nevertheless, TLR-3 was induced in L. donovani-
infected, as well as poly (I:C) treated 14M1.4 cells, but unlike
IRF-7, TLR-3 appeared to be promiscuously recruited to
phagosome membranes, at least after IRF-7 activation.
CD8
+ T cell responses are of notable importance for protection
against L. donovani, and vaccines which target CD8
+ T cells are
particularly effective against this infection in experimental models
[49,50]. Although the role of tissue resident macrophages as
antigen presenting cells has recently returned to the fore, with a
variety of studies demonstrating antigen capture and presentation
to B cells [13], the importance of these cells for the induction of T
cell immunity remains controversial [10]. Early studies suggested
that innate Type I IFN responses were associated with an
increased capacity for cross-priming [51,52] and might therefore
favour the induction of CD8
+ T cell responses to intracellular
pathogens. However, whilst a recent systems biology analysis of
the response to Yellow Fever vaccine has confirmed the induction
of a Type I IFN gene signature centred on IRF-7, this signature
was not directly predictive of the magnitude of the CD8
+ T cell
response [53]. Previous studies of MHC gene expression in
Leishmania-infected macrophages have reported inhibition of basal
and IFN-c-induced MHCI and MHCII gene expression in
BALB/c derived peritoneal macrophages [54]. However, in the
presence of the strong Irf-7-mediated response associated with
infection of 14M1.4 cells, we observed a reciprocal regulation of
genes related to MHCI- and MHCII-restricted antigen presenta-
tion, with elevated levels of transcripts for MHCI, TAP1 and
tapasin. A similar role for IRF-7 in regulating cross-presentation
has also recently been confirmed following adenoviral gene
delivery of Irf-7 into peritoneal macrophages [55]. Together,
these data suggest that further examination of the role of stromal
macrophages, as represented by 14M1.4 cells and macrophages of
the splenic marginal zone, in CD8
+ T cell priming is now
warranted.
In conclusion, we have shown that IRF-7 is indispensable for
effective control of L. donovani amastigotes in stromal macrophages
in vitro and in vivo. Our results suggest that IRF-7 may play a
similarly important role in the containment of other intracellular
pathogens.
Materials and Methods
Animals and parasites
C57BL/6 mice (CRUK, Margate, UK) were used at 6–10
weeks of age and housed under specific-pathogen free conditions.
B6.Irf-7
2/2 mice were obtained from the RIKEN BioResource
Center (Ibaraki, Japan) with kind permission of T. Taniguchi,
University of Tokoyo, Japan. Amastigotes of the Ethiopian LV9
strain of L. donovani were maintained by passage in B6.RAG1
2/2
mice. Mice were infected with 2–5610
7 amastigotes intravenously
Figure 6. Irf-7
2/2 MZM and MMM are defective in anti-leishmanial activity. (A–F) Parasite localisation in wild type and Irf-7
2/2 mice. Spleens
from naı ¨ve C57BL/6 (A) and Irf-7
2/2 (B) mice and C57BL/6 (C, E) and Irf-7
2/2 (D, F) mice infected with L. donovani for 5h or 24h, were stained for CD169
(green), SIGNR1 (red), Leishmania (white) and counterstained with DAPI (blue). Higher magnification inserts show localization of amastigotes (arrowed).
(G) Parasite load in the MZ of C57BL/6 mice (open bars) and B6.Irf-7
2/2 mice (black bars) was determined by counting the number of parasites per MZ
area *, p,0.05, **, p,0.01. (H) The number of amastigotes in CD169
+ MMM and SIGNR1
+ MZM of B6 (open bars) and Irf-7
2/2 (black bars) mice was
determined at 5h and 24h (n=64 MZ profiles, from 4 mice per time point per strain). Data are presented as fold change at 24h. ***, p,0.001. Scale bars;
100mm.
doi:10.1371/journal.ppat.1000813.g006
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dislocation as required.
Ethics statement
All experiments were approved by the University of York
Animal Procedures and Ethics Committee and performed under
UK Home Office license (‘Immunity and Immunopathology of
Leishmaniasis’ Ref # PPL 60/3708).
In vitro infection of cell lines
RAW 264.7 macrophages (American Type Culture Collection,
Rockville, MD) and 14M1.4 stromal macrophages ([23]; a gift
from D. Zipori, Weizmann Institute of Science, Rehovot, Israel)
were maintained in complete Dulbecco’s modified Eagle’s medium
(DMEM; Gibco) containing 5% FCS supplemented with 1 mM
sodium pyruvate, 2mM L-glutamine, 0.05 mM 2-mercaptoetha-
nol, 100U/ml penicillin and 100mg/ml streptomycin (all Gibco,
Paisley, UK). 14M1.4 cells express low levels of SIGNR1 but
undetectable levels of MARCO and CD169 (data not shown).
14M1.4 cells deficient in Irf-7 were generated by transfection with
lentiviral particles encoding shRNA for Irf-7 mRNA (SHVRS-
NM_016850, Sigma-Aldrich, St. Louis, MO). Transfected cells
were positively selected in complete media containing 5mg/ml
puromycin (Sigma-Aldrich, St Louis, MO) and clones were
generated by limited dilution. Irf-7 mRNA knock-down was
screened by RT-PCR and immuno-staining. Before use in
infection experiments, cells were collected by scraping with cell
scraper (BD Falcon) and 5610
5 cells in complete DMEM were
added to 24 well plates (Corning Inc. Corning, NY) containing
sterilised 13mm diameter coverslips (VWR International, Leics,
UK). After 24h, amastigotes were added at a multiplicity of
infection (MOI) of 10:1 (in 300ml complete DMEM). After 1h at
37uC, non-adherent cells and free amastigotes were removed and
cells were cultured for various times post infection (p.i.). In some
instances, 2mm latex beads (Bangs Laboratories, Fishers, IN) were
used in addition to or instead of amastigote infections. Cell lines
were treated for 2h with IFN-a (1000U/ml; PBL Interferon
Source, Piscataway, NJ) at the time of infection. To quantify
infection level, cells were fixed and permeabilised using 4%
paraformaldehyde + 0.1% Triton-X 100 (BDH) and coverslips
were mounted in Vectashield with DAPI (Vector laboratories,
Burlingame, CA). The proportion of cells infected and the number
of amastigotes per 100 host cells was calculated from triplicate
cultures per treatment group.
Microarray analysis
10
6 control or infected 14M1.4 and RAW264.7 cells were
incubated for 12 and 48 hours in T25 tissue culture flasks.
Samples were prepared in triplicate on three separate occasions,
with an average infection level of 3865% for 14M1.4 cells and
3668% for RAW264.7 cells. RNA was extracted from the cell
lines using Trizol according to the manufacturer’s protocol
(Sigma-Aldrich). One of the triplicate samples from each of the
three experiments were used for microarray analysis. RNA
concentration and integrity was established using 210 Bioanalyser
(Agilent Technologies, Palo Alto, CA). Extracted RNA was
reversed transcribed to cDNA using the Affymetrix GeneChip
one-cycle target labelling kit (Affymetrix, Santa Clara, CA)
according to the manufacturer’s recommended protocols and
hybridised to GeneChipH Mouse Genome 430 2.0 Genome
Arrays. Raw data processing was performed by using the
Affymetrix GCOS 1.2 software. After hybridization and scanning,
probe cell intensities were calculated and summarized for the
respective probe sets by means of the MAS5 algorithm. MAS5
normalised data were collected and analyzed by using the
ArrayAssist Expression software, Version 5.5 (Stratagene). Differ-
entially expressed genes were identified by using a two-class t test
where significance level was set at p . 0.05. Genes that were .2.0
fold up- or down-regulated between groups were selected. Data
from these studies have been deposited in the EBI ArrayExpress
data base (Accession #: E-MEXP-2554). Gene lists were
susbsequently analysed using Ingenuity Pathway Analysis (Inge-
nuity Systems, Redwood City, CA) and Expander (Shamir et al.,
2005) software.
Cell/parasite proliferation assay
Proliferation of macrophages and L. donovani amastigotes was
assessed by analysis of the loss of CFSE (Invitrogen, Paisley, UK)
fluorescence. Macrophages were incubated with 10mM CFSE in
PBS for 10 minutes at 37uC, washed repeatedly, and then plated as
above. At the appropriate times, macrophages were harvested and
analysed for CFSE fluorescence. To assess amastigote proliferation,
amastigotes labelled with CFSE as above prior to use for infection.
At appropriate times p.i., macrophages were lysed with 1.25mg/ml
saponin (BDH) in PBS. Released amastigotes were isolated by
centrifugation and labelled with 10mM cell tracker blue (Invitrogen,
Paisely, UK) for 20 minutes at 37uC, followed by specific anti-L.
donovani antibody (1:50 dilution of heat inactivated serum from an
infected hamster) and then goat anti-hamster alexa fluor 647
antibody (10mg/ml; Invitrogen, Paisley, UK). CFSE dilution of
macrophages and/or viable parasites was determined by flow
cytometry using a cyan flow cytometer (Dako). 20,000–50,000
events were analysed per sample at each time point (n=3).
Real-time reverse transcription-PCR (RT-PCR)
Macrophage RNA was isolated using an RNeasy kit according
to the manufacturer’s instructions (Qiagen, UK). RNA was reverse
transcribed to cDNA using the first-strand cDNA synthesis kit
according to manufacturer’s instructions (Invitrogen, Paisley, UK).
Primers for the specific amplification of hypoxanthine phosphor-
ibosyltransferase (HPRT) have been previously described
(45). Pre-
designed primers were used for the specific amplification of Irf-7
and Mx1 (PPM04696E and PPM05520A, respectively: Super-
array, Frederick, MD). PCR conditions for all primers were 95uC
(15s), 62uC (30s), and 60uC (30s) for 40 cycles. Real-time PCR was
performed with the SYBR green PCR kit in an ABI Prism 7000
sequence detection system (Applied Biosystems) according to
manufacturer’s instructions. Relative expression of target genes
was normalized to HPRT and was quantified by the formula 2-
DDCT where DDCT = (CT Target 2 CT HPRT)Treated 2 (CT
Target 2 CT HPRT)Control. Values are expressed as the mean of
triplicates 6 SE. Broken line indicates the expression of the
untreated control to which all samples were calibrated.
IRF-7 flow cytometry
For IRF-7 protein expression, cells were fixed in 4% PFA and
permeabilised on ice for 30 min with 0.1% Triton-X 100 buffer.
Cells were incubated with a polyclonal rabbit anti-IRF-7 antibody
(Zymed, San Francisco, CA) or control (rabbit IgG Calprologics
Inc. Harwick, MA) used at 5mg/ml. Primary antibody was detected
using a goat anti-rabbit alexa fluor 546 secondary antibody
(Invitrogen, Paisley, UK). Flow cytometric analysis was performed
with a CyAn flow cytometer and Summit v4.3 software (Dako).
Fluorescence microscopy
Macrophages were stained for MyD88 and IRF-7 after fixation
and permeabilised as above, but at room temperature. Cells were
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(Fluka, UK) in PBS for 2h at room temperature or at 4uC
overnight. Polyclonal rabbit anti-IRF-7 or control polyclonal sera
was used at 5mg/ml. Monoclonal rat anti-MyD88 (R&D Systems,
UK) or rat IgG2a (Invitrogen, Paisley, UK) was used at 5mg/ml.
Primary antibodies were incubated with cells for 1h at RT.
Primary antibodies were detected using the following secondary
antibodies (10mg/ml; 1h at RT) ; goat anti-rabbit alexa fluor 546
(Invitrogen, Paisley, UK), and goat anti-rat alexa fluor 488
(Invitrogen, Paisley, UK). Coverslips were mounted in ProLong
gold (Invitrogen, Paisley, UK) mounting medium. Immunofluo-
rescence staining of 8mm cryosections of spleen was performed
under same conditions except fixation/permeabilisation was
carried out using ice cold acetone for 10 min. Sections were
blocked as described above and antibodies were used as follows
(5mg/ml); rat anti-CD169 FITC conjugated (Serotec, UK), rat
IgG2a FITC isotype (Invitrogen), rat anti-SIGNR1 biotinylated
(Bachem, UK), rat IgM biotinylated (Invitrogen). Streptavidin
alexa fluor 633 (Invitrogen) was used to detect biotinylated
primary antibodies and IRF-7/amastigote staining was carried out
as above. Specificity of IRF-7 staining was determined by absence
of staining in sections taken from naı ¨ve and infected B6.Irf-7
2/2
mice. Similarly, no specific staining around L. donovani amastigotes
was observed following infection of 14M1.4 knock-down clones or
following in vivo infection of B6.Irf7
2/2 mice (Supplementary
Figure S6), confirming that the polyclonal anti-IRF-7 antibodies
did not react to Leishmania components. Sections counterstained
with 1mM DAPI (Invitrogen) in PBS for 10 minutes and mounted.
Slides were analysed on a 4 laser (7-line) Zeiss Meta invert
motorised microscope (Carl Zeiss, Germany) and images analysed
in LSM software (Carl Zeiss, Germany). Total numbers of
parasites within the MZ (and their distribution within macrophage
subsets) were determined from .5 sections per mouse, scoring all
MZ profiles observed in each section. Data were pooled across 3–5
mice per time point and each experiment was repeated
independently at least twice.
Statistical analysis
Statistical analysis was performed using two-tailed student t test
or Mann Whitney U test (as appropriate), with p ,0.05 considered
significant.
Supporting Information
Figure S1 CFSE dilution rates of host cells and L. donovani
amastigotes. (A) 14M1.4 and RAW264.7 cells were labeled with
CFSE and analysed for CFSE dilution by flow cytometry at
various times thereafter. The average number of divisions per 24h
was calculated over the entire 48h period and is shown in the
histogram. (B) Amastigotes were labeled with CFSE prior to
infection of 14M1.4 and RAW264.7 cells. At various times post
infection, cells were lysed, amastigotes counterstained with anti-L.
donovani and with cell tracker blue, and CFSE dilution analysed by
flow cytometry. Histograms show percentage of amastigotes with
CFSE dilution representing .1o r.2 divisions at each time point
analysed.
Found at: doi:10.1371/journal.ppat.1000813.s001 (0.79 MB TIF)
Figure S2 Network maps of differentially expressed genes 12h
after L. donovani infection. 14M1.4 and RAW264.7 cells were
infected with L. donovani amastigotes and 12h later, RNA was
extracted and used for gene profiling. Genes showing 2-fold up or
down regulation were analysed using Ingenuity Pathways to
identify networks. The 5 top scoring (for 14M1.4 cells) networks
and the single network (for RAW264.7 cells) containing .20
differentially regulated genes are shown (A–E) 14M1.4 cells (F)
RAW264.7.
Found at: doi:10.1371/journal.ppat.1000813.s002 (1.17 MB TIF)
Figure S3 Network maps of differentially expressed genes 48h
after L. donovani infection. 14M1.4 and RAW264.7 cells were
infected with L. donovani amastigotes and 48h later, RNA was
extracted and used for gene profiling. Genes showing 2-fold up or
down regulation were analysed using Ingenuity Pathways to
identify networks. The 5 top scoring (for 14M1.4 cells) networks
and the single network (for RAW264.7 cells) containing .20
differentially regulated genes are shown (A–E) 14M1.4 cells (F)
RAW264.7.
Found at: doi:10.1371/journal.ppat.1000813.s003 (1.19 MB TIF)
Figure S4 Expression of IRF-7 in RAW 264.7 cells and bone
marrow macrophages. (A) Real-time RT-PCR showing Irf-7
mRNA accumulation in RAW264.7 cells following exposure to
L. donovani at MOI of 30:1 (diamond), 10:1 (invert triangle), 1:1
(triangle) or after exposure to 100mg/ml poly(I:C) (open square).
(B) Expression of IRF-7 by confocal microscopy (red, IRF-7; blue,
DAPI) in uninfected (left) and L. donovani-infected (centre)
RAW264.7 cells, acquired and shown using the same setting as
images shown in Figure 2. Right hand panel shows same image
with IRF-7 intensity amplified to show lack of close association of
IRF-7 and Leishmania phagosomes in RAW264.7 cells (c.f.
Figure 3C and F). Scale bar: 10mm (C) 10-day CSF-1 bone
marrow-derived macrophages without infection (left panel) and 6h
after L. donovani infection (right panel) stained for IRF-7 (red) and
counterstained with DAPI (blue). IRF-7 is not induced by infection
and does not associate tightly with the L. donovani phagosome.
Found at: doi:10.1371/journal.ppat.1000813.s004 (1.25 MB TIF)
Figure S5 NO production by 14M1.4 cells. Nitric oxide
production by 14M1.4 cells was determined in culture superna-
tants by Griess assay at the times indicated following infection with
L. donovani amastigotes (6–48h) or at 24h after addition of 100mg/
ml Poly (I,C) or IFNc (100U/ml) plus LPS (10ng/ml). Data
represent mean 6 SEM from triplicate cultures.
Found at: doi:10.1371/journal.ppat.1000813.s005 (0.26 MB TIF)
Figure S6 Specificity of IRF-7 polyclonal antibody. (A, B)
14M1.4 cells (A) and knockdown line KD#1 (B) were infected
with L. donovani and stained at 24h for IRF-7. (C,D) L. donovani
infected B6 mice (C) and B6.Irf7
2/2 mice (D) were infected for 5h
and then stained for IRF-7. No phagosomal staining of IRF-7 was
observed in KD#1 or in B6.Irf7
2/2 mice, confirming that this
antibody does not cross react with Leishmania components.
Found at: doi:10.1371/journal.ppat.1000813.s006 (4.89 MB TIF)
Table S1 Up- and down-regulated genes in 14M1.4 cells at 12h
Found at: doi:10.1371/journal.ppat.1000813.s007 (0.14 MB XLS)
Table S2 Up- and down-regulated genes in 14M1.4 cells at 48h
Found at: doi:10.1371/journal.ppat.1000813.s008 (0.12 MB XLS)
Table S3 Up- and down-regulated genes in RAW264.7 cells at
12h
Found at: doi:10.1371/journal.ppat.1000813.s009 (0.03 MB XLS)
Table S4 Up- and down-regulated genes in RAW264.7 cells at
48h
Found at: doi:10.1371/journal.ppat.1000813.s010 (0.03 MB XLS)
Video S1 IRF-7-MyD88 association in untreated 14M1.4 cells
(red, IRF-7; green, MyD88; blue, DAPI.). For details, see text.
Found at: doi:10.1371/journal.ppat.1000813.s011 (2.10 MB
MOV)
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14M1.4 cells (red, IRF-7; green, MyD88; blue, DAPI.). For details,
see text.
Found at: doi:10.1371/journal.ppat.1000813.s012 (1.15 MB
MOV)
Video S3 3D opacity projections of 14M1.4 macrophages
infected for 24hrs with L. donovani amastigotes, and labelled with
IRF-7 (red) and LAMP-1 (green) antibodies. Successive rotations
show DAPI, IRF-7 and then LAMP-1. Note co-localisation of
LAMP1 and IRF7 in phagosome left centre of image. For details,
see text.
Found at: doi:10.1371/journal.ppat.1000813.s013 (9.81 MB
MOV)
Video S4 MMM in L. donovani infected B6 mouse showing
phagosomal localisation of IRF-7 (CD169
+ green, IRF-7, red;
LV9, white; DAPI, blue). For details, see text.
Found at: doi:10.1371/journal.ppat.1000813.s014 (1.77 MB
MOV)
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